Geron Corporation (GERN) Eyes Profitability in 2026 amid Restructuring Drive [Yahoo! Finance]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Yahoo! Finance
its 2026 outlook, forecasting $220–240 million in RYTELO (imetelstat) revenue and $230–240 million in operating expenses following a recent restructuring. The blood-cancer-focused company expects stronger growth in the second half of the year as it increases outreach to physicians and patients. Geron is prioritizing U.S. commercialization, international expansion, and progress in its Phase 3 IMpactMF trial. RYTELO, a first-in-class telomerase inhibitor approved in the U.S. and EU for lower-risk MDS-related anemia, continues to build clinical support, with new IMerge data presented at the 2025 ASH meeting. The company also amended its loan agreement with Pharmakon Advisors, securing access to up to $125 million through July 2026. On December 16, the company embarked on a restructuring drive to achieve profitability in the second half of 2026. The company is in the process of trimming its workforce by nearly a third, a move expected to reduce operating expenses. However, it is also
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron Corporation (GERN) Streamlines Operations, Secures Financing, Eyes 2026 Growth [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Provides 2026 Financial GuidanceGlobeNewswire
- Geron (GERN) Plans Restructuring to Cut Costs, H.C. Wainwright Stays Neutral [Yahoo! Finance]Yahoo! Finance
- Geron: From Launch Hype To Later-Line Gravity [Seeking Alpha]Seeking Alpha
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
GERN
Earnings
- 11/5/25 - In-Line
GERN
Sec Filings
- 1/12/26 - Form 8-K
- 1/6/26 - Form 8-K
- 1/5/26 - Form 4
- GERN's page on the SEC website